Neuland Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
16,857.25
-131.25 (-0.77%)
BSENSE

Dec 05

BSE+NSE Vol: 16.46 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
807.03
750.45
780.74
514.88
458.73
446.82
367.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
807.03
750.45
780.74
514.88
458.73
446.82
367.23
Raw Material Cost
389.12
288.12
303.99
217.82
244.00
210.38
196.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-91.97
6.23
-6.46
-18.38
-45.58
7.03
-6.42
Employee Cost
153.84
136.21
128.85
100.63
90.47
68.41
59.53
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
85.33
78.44
77.66
66.25
65.12
55.06
43.27
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
80.67
55.86
42.30
50.66
36.20
31.23
30.31
Total Expenditure (Excl Depreciation)
616.99
564.86
546.34
416.98
390.21
372.11
323.61
Operating Profit (PBDIT) excl Other Income
190.04
185.59
234.40
97.90
68.52
74.71
43.62
Other Income
9.66
9.14
5.09
0.75
2.34
1.30
1.09
Operating Profit (PBDIT)
199.70
194.73
239.49
98.65
70.86
76.01
44.71
Interest
9.95
3.73
6.65
6.03
7.40
8.88
8.81
Exceptional Items
0.00
20.63
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
189.75
211.63
232.84
92.62
63.46
67.13
35.90
Depreciation
42.73
32.35
28.09
25.97
23.81
18.13
15.84
Profit Before Tax
147.01
179.26
204.75
66.65
39.65
49.00
20.05
Tax
36.25
48.55
53.63
18.22
10.55
12.39
5.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
110.75
130.72
151.13
48.43
29.11
36.60
14.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
110.75
130.72
151.13
48.43
29.11
36.60
14.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
110.75
130.72
151.13
48.43
29.11
36.60
14.40
Equity Capital
12.90
12.90
12.90
12.90
12.90
12.90
12.90
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
795.05
0.00
0.00
Earnings per share (EPS)
85.85
101.33
117.16
37.54
22.57
28.37
11.16
Diluted Earnings per share
86.32
101.88
117.79
37.74
22.69
28.53
11.22
Operating Profit Margin (Excl OI)
23.55%
24.73%
30.02%
19.01%
14.94%
16.72%
11.88%
Gross Profit Margin
23.51%
28.2%
29.82%
17.99%
13.83%
15.02%
9.78%
PAT Margin
13.72%
17.42%
19.36%
9.41%
6.35%
8.19%
3.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 7.54% vs -3.88% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is -15.28% vs -13.50% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 2.40% vs -20.82% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 166.76% vs -43.91% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of Neuland Labs. With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
807.03
0
807.03
Other Operating Income
0.00
0.00
0.00
Total Operating income
807.03
0
807.03
Raw Material Cost
389.12
0
389.12
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-91.97
0
-91.97
Employee Cost
153.84
0
153.84
Power Cost
0.00
0
0.00
Manufacturing Expenses
85.33
0
85.33
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
80.67
0.00
80.67
Total Expenditure (Excl Depreciation)
616.99
0
616.99
Operating Profit (PBDIT) excl Other Income
190.04
0.00
190.04
Other Income
9.66
0
9.66
Operating Profit (PBDIT)
199.70
0
199.70
Interest
9.95
0
9.95
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
189.75
0
189.75
Depreciation
42.73
0
42.73
Profit Before Tax
147.01
0
147.01
Tax
36.25
0
36.25
Provisions and contingencies
0.00
0
0.00
Profit After Tax
110.75
0
110.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
110.75
0
110.75
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
110.75
0
110.75
Equity Capital
12.90
0
12.90
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
85.85
0
85.85
Diluted Earnings per share
86.32
0
86.32
Operating Profit Margin (Excl OI)
23.55%
0%
0.00
23.55%
Gross Profit Margin
23.51%
0%
0.00
23.51%
PAT Margin
13.72%
0%
0.00
13.72%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 807.03 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 7.54% vs -3.88% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 110.75 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -15.28% vs -13.50% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 190.04 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 2.40% vs -20.82% in Sep 2024

Half Yearly - Interest
Interest 9.95 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 166.76% vs -43.91% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.55%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024